Burning Rock Biotech Limi... (BNR)
5.47
-0.23 (-4.04%)
At close: Mar 24, 2025, 3:57 PM
5.68
3.84%
After-hours: Mar 24, 2025, 04:00 PM EDT
-4.04% (1D)
| Bid | 3.99 |
| Market Cap | 56.12M |
| Revenue (ttm) | 507.71M |
| Net Income (ttm) | -424.89M |
| EPS (ttm) | -5.75 |
| PE Ratio (ttm) | -0.95 |
| Forward PE | -11.5 |
| Analyst | n/a |
| Ask | 7.04 |
| Volume | 398 |
| Avg. Volume (20D) | 5,975.8 |
| Open | 5.50 |
| Previous Close | 5.70 |
| Day's Range | 5.47 - 5.50 |
| 52-Week Range | 2.62 - 8.99 |
| Beta | 0.56 |
About BNR
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestina...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 12, 2020
Employees 786
Stock Exchange NASDAQ
Ticker Symbol BNR
Website https://www.brbiotech.com
3 months ago
+13.61%
Burning Rock Biotech shares are trading higher aft...
Unlock content with
Pro Subscription
5 months ago
-4.13%
Burning Rock Biotech shares are trading lower. The company announced the resignation of its director and CFO.
